Solvay Pharmaceuticals, Inc.
Records under this name other than patents Solvay Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Solvay Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,702,155 | Metered dose dispenser Formerly held Term ended Term ended Sep 18, 2021 · From the USPTO record | Term ended | Term ended Sep 18, 2021 | From the USPTO record |
| US 7,547,708 | N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereof Lapsed on the fee record Ended Jun 16, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 16, 2021 | From the USPTO record |
| US 7,297,699 | Piperazine and piperidine compounds Term ended Ended no later than May 10, 2021 · From the USPTO record | Term ended | Ended no later than May 10, 2021 | From the USPTO record |
| US 7,435,738 | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) Lapsed on the fee record Ended Oct 14, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 14, 2020 | From the USPTO record |
| US 7,456,182 | Phenylpiperazines Term ended Ended no later than Aug 22, 2020 · From the USPTO record | Term ended | Ended no later than Aug 22, 2020 | From the USPTO record |
| US 7,375,127 | Novel Tetrahydrocarbazole Derivatives Having Improved Biological Action and Improved Solubility as Ligands of G-Protein Coupled Receptors (GPCRS) Formerly held Lapsed on the fee record Ended May 20, 2020 · High confidence | Lapsed on the fee record | Ended May 20, 2020 | High confidence |
| US 7,342,032 | Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity Lapsed on the fee record Ended Mar 11, 2020 · From the USPTO record | Lapsed on the fee record | Ended Mar 11, 2020 | From the USPTO record |
| US 7,271,189 | 1H-imidazole derivatives as cannabinoid receptor modulators Lapsed on the fee record Ended Sep 18, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2019 | From the USPTO record |
| US 7,605,162 | Phenylpiperazine Lapsed on the fee record Ended Oct 20, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 20, 2017 | From the USPTO record |
| US 6,906,059 | Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances Lapsed on the fee record Ended Jun 14, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2017 | From the USPTO record |